WuXi Global Forum 2023 - Advancing Breakthroughs for Patients

Actions Panel

WuXi Global Forum 2023 - Advancing Breakthroughs for Patients

WuXi Global Forum 2023 - Advancing Breakthroughs for Patients

When and where

Date and time


Continental Ballroom 4-6, Ballroom Level of Tower 3, Hilton San Francisco Union Square 333 O'Farrell Street San Francisco, CA 94102

Map and directions

How to get there

About this event

Dear Colleagues and Friends,

WuXi AppTec is pleased to announce the distinguished speakers and agenda for WuXi Global Forum 2023, which will take place on January 10, 2023 from 1:00-6:00PM PST at Hilton San Francisco Union Square in concurrent with the J.P. Morgan Healthcare Conference.

The theme of this year’s forum is B.O.L.D. We will reflect on the state of innovation and highlight our industry’s notable advances in tackling innovation challenges to build an impactful future for patients: Breaking Barriers, Opening New Horizons, Leading Next Generation, and Delivering on the Promise for Patients.

WuXi Global Forum 2023 is complimentary and by invitation.

AGENDA (The time below is PM, Pacific Standard Time)

For the full program and each speaker’s bio, please click HERE

1:00 Onsite Check-in and Networking

1:30 Welcome

Hui Cai, Program Chair and Vice President, WuXi AppTec

1:35 Opening Remarks

Minzhang Chen, Co-CEO, WuXi AppTec

1:45 State of Innovation 2023

Todd Golub, Director, Broad Institute of MIT & Harvard

John Ngai, Director, NIH BRAIN Initiative

Vijay Pande, General Partner, Andreessen Horowitz

Aviv Regev, Head, Genentech Research and Early Development

Michael Severino, CEO, Tessera Therapeutics; CEO-Partner, Flagship Pioneering

Session Leader: Mathai Mammen, Executive Vice President of R&D, Johnson & Johnson Pharmaceuticals (in transition)

Spotlight on B.O.L.D.

2:30 Breaking Barriers: Druggability Redefined

Ros Deegan, CEO, OMass Therapeutics

Dan Nomura, Professor of Chemical Biology and Molecular Therapeutics, University of California, Berkeley

Nancy Pryer, CSO, Ambagon Therapeutics

Lance Stewart, Chief Strategy and Operations Officer, Institute for Protein Design, University of Washington

Session Leader: C. Simone Fishburn, VP & Editor in Chief, BioCentury Inc.

3:10 Opening New Horizons: Spotlight on RNA Therapeutics

Tom Barnes, CEO, Orna Therapeutics

John Mendlein, Chairman, Laronde; Executive Partner, Flagship Pioneering

Romesh Subramanian, CEO, Ascidian Therapeutics

Michelle Werner, CEO, Alltrna; CEO-Partner, Flagship Pioneering

Session Leader: Nina Kjellson, General Partner, Canaan

3:50 Leading Next Generation of Cell and Gene Therapies

Ken Drazan, Chairman, CEO, Co-Founder, ArsenalBio

Keith Gottesdiener, President & CEO, Prime Medicine

Laura Shawver, President & CEO, Capstan Therapeutics

Catherine Stehman-Breen, CEO, Chroma Medicine

Session Leader: Edward Hu, Vice Chairman, Global Chief Investment Officer, WuXi AppTec

4:30 Delivering on the Promise for Patients

Giulio Draetta, SVP & CSO, MD Anderson Cancer Center

Stephen Hauser, Director, UCSF Weill Institute for Neurosciences; Professor, Department of Neurology, University of California, San Francisco

Joseph Wu, Director of Stanford Cardiovascular Institute; President-Elect of American Heart Association

Session Leader: Christiana Bardon, Co-Managing Partner of BioImpact Capital, an MPM affiliate

5:05 Building an Impactful Future

Juergen Eckhardt, SVP & Head of Leaps by Bayer

Sofia Ioannidou, Partner, Andera Partners

Carol Suh, Partner, ARCH Venture Partners

Sze-Wee Tan, Assistant Chief Executive, Innovation and Enterprise Group, Singapore Agency for Science, Technology and Research (A*STAR)

Session Leader: Michal Preminger, Regional Head, Johnson & Johnson Innovation East North America

5:50 Closing Remarks

Steve Yang, Co-CEO, WuXi AppTec